MENU
TTNP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Titan Pharmaceuticals (TTNP) Ownership - Who owns Titan Pharmaceuticals?
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
400 Oyster Point Boulevard
Phone
+1 650 244-4990
Employees
4
Web
https://www.titanpharm.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.35M
P/E Ratio
N/A
Total Cash
4.09M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.61
Dividend Yield
N/A
Total Cash/Share
4.48
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TTNP
Capitalization
3.35M
P/E Ratio
N/A
Risk (Beta)
1.61
Dividend Yield
N/A
Total Cash
4.09M
Total Cash/Share
4.48
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.99M
P/B Ratio
1.37
Cash Flow
N/A
Earnings
-6.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
12.22
Current Revenue Per Employee
250.00
Dividends Per Share - Security
N/A
EBITDA
-7.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-211.58
Shares Held By Institutions
36.6K
Shares Outstanding - Current
914K
Total Liabilities
356K
Total Volume MTD
N/A
Value
-1
Gain YTD
12.294
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of proprietary therapeutics for the treatment of serious medical disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
400 Oyster Point Boulevard
Phone
+1 650 244-4990
Employees
4
Web
https://www.titanpharm.com